Earnings call transcript: REPAY Holdings Q1 2026 EPS miss, cautious market reaction

REPAY posted Q1 2026 EPS of -$0.12 versus the $0.21 consensus, a negative surprise of 157.14%, while revenue came in at $77.3 million, slightly below expectations. Offsetting the miss, adjusted EBITDA was $34.4 million with a 43% margin, free cash flow was $5.4 million, and the company reaffirmed 2026 guidance for $340 million-$346 million in revenue and $141 million-$146 million in adjusted EBITDA. Shares rose 1.04% after hours, helped by the KUBRA acquisition rationale and continued product momentum in digital wallet and AI-enabled tools.

Analysis

RPAY’s setup is more interesting than the headline EPS miss implies: the business is transitioning from a quarterly earnings print story to a balance-sheet-and-integration story. The market is likely giving credit to the combination of durable recurring bill-pay volumes, visible backlog conversion into the back half, and the prospect that KUBRA expands the addressable market enough to offset near-term dilution from leverage and integration costs. In other words, the stock is trading less on current-quarter noise and more on whether management can prove the acquired revenue base is sticky and cross-sellable within 2-3 quarters.

The key second-order effect is that the acquisition raises the bar on execution while also improving the strategic defense of the franchise. If KUBRA closes on time and integration is clean, the company’s scale should improve partner retention and pricing leverage with software partners; if the integration slips, the leverage target becomes the pressure point, not the top line. That creates a sharp asymmetry: downside is likely to show up first in multiple compression if net leverage stays elevated while synergy capture is delayed, even if reported growth looks fine.

The most underappreciated risk is that investor patience may be shorter than management’s 18-month de-levering framework, especially if consumer volumes remain steady but unspectacular and the political-media contribution proves more episodic than catalytic. On the upside, the KUBRA narrative can re-rate the stock if management can demonstrate early synergy capture and a clean post-close free-cash-flow trajectory; that would shift RPAY from a small-cap payments compounder to a scaled, recurring bill-pay platform with a more defensible valuation floor.

Key Decisions for Investors

• Long RPAY common into a confirmed KUBRA close, but size it as a 6-12 month catalyst trade; upside is multiple expansion if the market starts underwriting synergy capture, while downside is bounded by recurring-revenue defensiveness.
• Pair trade: long RPAY / short a higher-multiple fintech with weaker recurring bill-pay exposure over the next 1-2 quarters; RPAY has a clearer self-help path, while peers remain more exposed to growth disappointment.
• If available, buy RPAY Jan/Apr calls and fund with upside calls sales; the risk/reward is attractive if KUBRA closes and management validates de-levering, but premium should be kept tight because integration risk is real.
• Add only on post-close evidence: wait for the first earnings print after KUBRA closes and look for a 2-3 quarter synergy roadmap before increasing exposure; that is the inflection point where the bear case becomes harder to defend.
• For event-driven traders, short any sharp post-announcement squeeze if the stock re-rates above the implied value of the standalone business before integration proof; the market may be pricing execution too early.